ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma

Abstract 1q21 gain is a common cytogenetic abnormality featuring high‐risk multiple myeloma (HRMM). However, the molecular mechanism underlying the adverse prognostic effect of 1q21 gain remains largely unclear. Here, we report that ARNT/HIF‐1β, a 1q21 gene, is highly expressed in HRMM and induced b...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Chuan Wu, Ting Yang, Yingmin Liu, Yicheng Lu, Yanping Yang, Xiaobo Liu, Xuelian Liu, Long Ye, Yue Sun, Xue Wang, Qingchao Li, Peiyu Yang, Xiaoyuan Yu, Sujun Gao, Shaji Kumar, Fengyan Jin, Yun Dai, Wei Li
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2018-08-01
Reeks:	Cancer Medicine
Onderwerpen:	1q21 gain ARNT/HIF‐1β drug resistance hypoxia multiple myeloma
Online toegang:	https://doi.org/10.1002/cam4.1596
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!